MRI heart flow study to understand heart muscle damage
Part of Heart & circulation clinical trials.
This study uses a special heart MRI to look at blood-flow patterns and how they relate to heart muscle injury. It may help researchers better understand different types of heart damage by comparing people with and without injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 20 and 80 years old
- Have a heart MRI scheduled (for any reason)
- Be able to hold your breath during the scan
- Be able to understand the study and sign consent
- Tell the team about any implanted devices or metal in/around your body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the lymphatic system and heart tissue after a heart attack (STEMI) in people who had prompt catheter treatment. It uses heart MRI to understand healing and may help researchers improve care after a heart attack.
This trial uses heart MRI scanning to create normal reference measurements in women who appear to have no heart blood-flow problems. It may help doctors compare future MRI results and better interpret scans when symptoms happen.
This study uses a special MRI approach to measure details of your heart muscle in people with certain heart problems. It may help researchers better understand how different conditions affect the heart and how those changes can be measured.
This study tests a special imaging scan to measure how well blood flows through heart muscle in patients with chest pain and suspected heart disease. The results may help doctors better diagnose heart conditions without invasive procedures.
This study follows people 18 and older who have had a specific type of heart attack (STEMI). It aims to better understand them using a heart MRI scan, which may help improve how these patients are evaluated and cared for.
This study uses heart MRI scans to find markers that predict outcomes in people with ischemic heart disease, including those who have had a heart attack. It may help doctors better understand your condition and guide future care.
Hear when a new Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.